COMP <GO>
STKE vs BHST // EV/EBITDA & P/E VALUATION
Sol Strategies Inc. (NASDAQ) VS. BioHarvest Sciences Inc. (NASDAQ) • 15-METRIC TALLY: STKE 1
— BHST 1
■ METRIC PARITY
LAST: $1.28 (-1.16%) • MKT CAP: $50.5M
valuation
—
LAST: $1.66 (-5.68%) • MKT CAP: $37.6M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STKE VS. BHST)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STKE | BHST | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 59.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -16.20% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -32.30% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 37.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 5/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.1 | 48.0 | -5.96 | BHST | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $50.5M | $37.6M | $12.9M | STKE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STKE REV | BHST REV | STKE GROSS % | BHST GROSS % | STKE FCF | BHST FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $34.5M | — | 59.3% | — | -$9.6M |
| FY 2024 | — | $25.2M | — | 55.4% | — | -$9.5M |
| FY 2023 | — | $12.7M | — | — | — | -$8.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STKE // BETA —
BHST // BETA —